---
title: "The provision of West London Targeted Lung Health Check Programme"
ocid: "ocds-h6vhtk-0776c8"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0776c8"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0776c8.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0776c8.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "The Royal Marsden NHS Foundation Trust"
published: "2026-09-21"
---

# The provision of West London Targeted Lung Health Check Programme

Buyer: The Royal Marsden NHS Foundation Trust  
Current stage: Award  
OCID: ocds-h6vhtk-0776c8

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0776c8)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0776c8.json)

## Summary

The Royal Marsden NHS Foundation Trust, on behalf of RM Partners Cancer Alliance, is procuring a targeted lung cancer screening service across North West and South West London. The programme is for people aged 55 to 74 with a history of smoking who are at increased risk of lung cancer. It covers identifying and inviting eligible people, carrying out lung health checks, referring people for low-dose CT scans where appropriate, making onward clinical referrals and providing access to smoking cessation support. Delivery requires collaboration across primary care, diagnostic and secondary care settings and compliance with national quality and assurance requirements. The main service category is medical imaging, within a wider healthcare screening pathway.

The process has reached the award stage under the Health Care Services (Provider Selection Regime) Regulations 2023, using a direct award without prior publication of a competition. InHealth Limited was selected as supplier and the contract is recorded as active and signed on 21 September 2026. The contract value is £28,452,105 for an initial period from 5 October 2026 to 4 April 2029, with an optional extension to 4 April 2030. The authority’s decision used five criteria: quality and innovation at 30%, value at 20%, integration, collaboration and sustainability at 20%, access, health inequalities and choice at 20%, and social value at 10%. One bid was recorded. The standstill representation deadline was 1 October 2026.

This requirement indicates demand for a large-scale, end-to-end lung cancer screening provider able to manage the full pathway from participant identification and invitation through assessment, imaging, clinical decision-making and onward referral. Strong competitors would need experience delivering safe, high-quality screening and diagnostic services across community, primary care, diagnostic and secondary care environments. Credibility would also depend on scalable operations, efficient use of resources, continuous service or process improvement, and the ability to integrate with NHS and wider health and social care partners. Providers should be able to improve access for eligible high-risk populations, reduce health inequalities, support patient choice and smoking cessation, demonstrate measurable patient and population-health benefits, and provide wider economic, social and environmental value in London.

## Notice

West London Targeted Lung Health Check Programme: Royal Marsden Hospital on behalf of RM Partners Cancer Alliance

### Lot Information

Lot 1

The Lung Cancer Screening Programme delivers targeted lung health checks to people at increased risk of lung cancer (aged 55-74 with a history of smoking) with the aim of detecting the disease earlier, improving outcomes and reducing health inequalities. The service includes identification and invitation of eligible individuals, lung health assessments leading to referral for low-dose CT scanning where indicated, appropriate onward referral, and access to smoking cessation support. The programme is delivered collaboratively across primary care, diagnostic and secondary care settings and is governed by national quality and assurance requirements.

The Royal Marsden NHS Foundation Trust are intending to award a contract to an existing provider following a direct award process C under The Health Care Services (Provider Selection Regime) Regulations 2023.

The lifetime value of the contract (2.5 years with an optional 1 year extension possible) is PS28,452,105.

Contract start date: 05/10/2026
Initial contract end date: 04/04/2029
Maximum end date (including optional extension): 04/04/2030

### Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 01/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/089313-2026 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 21 Sep 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £28,452,105 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | The Royal Marsden NHS Foundation Trust |
| Locality | LONDON |
| Postcode area | South West London |
| Postcode | SW3 6JJ |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI33 Kensington & Chelsea and Hammersmith & Fulham |
| Local authority | Kensington and Chelsea |
| Electoral ward | Stanley |
| Westminster constituency | Chelsea and Fulham |
| Delivery location | TLI London |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | InHealth Limited |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85150000 - Medical imaging services

## Release History

- 21 Sep 2026 at 16:12 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/089313-2026

## Notice URLs

- http://www.inhealthgroup.com
- https://www.england.nhs.uk/
- https://www.royalmarsden.nhs.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0776c8. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0776c8.json.